Pediatric Oncology

Latest News


Latest Videos


CME Content


More News

Eribulin has demonstrated a high level of antitumor activity that was equivalent or superior to vincristine across several sarcoma xenograft models, including at low dose levels, suggesting the drug may effectively treat pediatric patients with sarcoma.

The FDA has awarded a $600,000 grant for a phase I clinical trial of a genetically reprogrammed herpes simplex virus in young cancer patients with relapsed non-central nervous system (CNS) solid tumors such as sarcomas and neuroblastomas.

Coloring for Chemo/Comfort is a nonprofit organization in Nevada started by Amy Villarele-Hardy and Nina Lawyer in November 2009.